Oscar Health, Inc. (OSCR) Intrinsic Value

DCF-based fair value calculation with Bear, Base, and Bull scenarios

Popular:

Oscar Health, Inc. (OSCR)

View Full Profile →

Intrinsic Value (DCF)

Current$17.38
Intrinsic$8.00
-54%
$6.92$8.00$10.05
Current price reflects execution expectations above 25% growth — not unreasonable for quality businesses.
Range: Bear $7 → Bull $10. Current price implies expectations above the base case, closer to bull expectations.
Current price reflects assumptions at the upper end of our valuation range (bull case: $10).
Discount ↓Growth →21%23%25%27%
8%$9$9$9$10
10%$8$8$8$8
12%$7$7$7$7
14%$6$7$7$7

Bull Case

  • Bull case ($10) with 30% growth, 9% discount rate

Bear Case

  • Bear case ($7) implies 60% downside at 20% growth, 12% discount
  • Trading 54% above base case — execution must exceed assumptions to justify
  • Price exceeds bull case ($10) — requires exceptional execution
Loading charts...

5-Year Net Income Projection

Year 1$31.79M
Year 2$39.74M
Year 3$49.67M
Year 4$62.09M
Year 5$77.61M
Terminal$1.14B

📐 Model Inputs

Growth Rate25.0%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate10.0%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Net Income$25.43MTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
ℹ️

DCF estimates based on historical growth rates extrapolated forward. Uses Net Income (FCF not meaningful for insurers). See FAQ below for full methodology.

Frequently Asked Questions

Is OSCR stock undervalued or overvalued?
🔴 OVERVALUED

OSCR trades at $17.38 vs. our DCF-derived intrinsic value of $7.42, implying -55% downside. Using a 10.0% WACC and 25.0% FCF growth assumption, the current price requires growth rates above our estimates to be justified. Even our bull case ($8.84) suggests limited upside.

What is OSCR's intrinsic value?

Using a 5-year DCF model: Base FCF of $25M, projected at 25.0% 5Y CAGR (best of revenue, EPS, or FCF growth), discounted at 10.0% WACC, with 3.0% terminal growth. Terminal value calculated via Gordon Growth Model: TV = FCF₅ × (1+g) / (WACC−g). After deducting $-1.23B net debt and dividing by 0.27B shares: Bear $6.45 | Base $7.42 | Bull $8.84. Current price $17.38 implies -55% to base case.

How is OSCR's fair value calculated?

DCF Methodology:

① Project FCF years 1-5 using 25.0% growth derived from 5-year historical CAGR (best of revenue, EPS, or FCF growth, with 8% floor and 25% cap).

② Calculate terminal value at year 5 using perpetuity growth model with g=3.0%.

③ Discount all cash flows to PV using WACC=10.0%.

④ Sum PV of explicit period + PV of terminal value = Enterprise Value ($745M).

⑤ Subtract net debt, divide by shares outstanding.

Sensitivity analysis available above—adjust WACC ±2% or growth ±3% to stress-test the valuation. Implied EV/FCF multiple: 29.3x.